文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病医院感染防控

难民与寻求庇护者中的抗菌药物耐药性:全球系统综述与Meta分析

Antimicrobial resistance among refugees and asylum seekers: a global systematic review and meta-analysis.
PubMed 文献 · Lancet Infect Dis · 2024-11-08

该全球系统综述与Meta分析检索2015年1月1日至2023年10月23日文献,纳入41篇报告16970名难民与寻求庇护者耐药菌携带或感染的研究。难民与寻求庇护者携带或感染任一耐药菌的可能性高于东道国人群(7849例 vs 81283例;OR 2.88,95%CI 2.61-3.18;I²=94%)。

要点

  • 难民与寻求庇护者任一耐药菌携带或感染风险高于东道国人群(OR 2.88,95%CI 2.61-3.18)。
  • 多药耐药革兰阴性菌患病率范围4.2%至60.8%,耐甲氧西林金黄色葡萄球菌0.92%至73%。
  • 产超广谱β-内酰胺酶革兰阴性菌患病率范围1.6%至61.1%。

核心结论

  • 难民与寻求庇护者抗菌药物耐药携带与感染风险增加,数据提示其可能暴露于支持耐药出现的条件,包括居住拥挤营地及面临卫生与疫苗系统障碍。
  • 需要更多全球与区域抗菌药物耐药数据,通过加强监测规划与卫生保健设施,尤其在低收入与中等收入国家。
  • 需要加大努力推动感染预防与控制(包括疫苗接种)、抗菌药物管理、针对高风险群体的治疗策略、这些风险人群获得优质卫生保健,并解决居住与过境条件差等风险因素。

研究设计与样本

  • 系统综述与Meta分析,检索Ovid(MEDLINE与Embase)及PubMed于2015年1月1日至2023年10月23日发表的同行评议原始研究。
  • 纳入报告任何国家难民或寻求庇护者实验室确诊耐药菌携带或感染的文章。
  • 共识别884篇文章,41篇报告16970名难民与寻求庇护者的抗菌药物耐药患病率并纳入分析。

主要发现

  • 多药耐药革兰阴性菌报告于26项研究,患病率范围4.2%至60.8%。
  • 耐甲氧西林金黄色葡萄球菌报告于24项研究,患病率范围0.92%至73%。
  • 产超广谱β-内酰胺酶革兰阴性菌报告于20项研究,患病率范围1.6%至61.1%。
  • 难民与寻求庇护者任一抗菌药物耐药携带或感染可能性高于东道国人群(7849例 vs 81283例;OR 2.88,95%CI 2.61-3.18;I²=94%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 异质性I²=94%。
  • 需要更多全球与区域抗菌药物耐药数据,通过加强监测规划与卫生保健设施,尤其在低收入与中等收入国家。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Refugees and asylum seekers might have an increased risk of antimicrobial resistance (AMR) carriage or infection due to several factors, with conflict and war known to accelerate the spread of AMR. However, data are scarce on prevalence and risk factors for AMR among refugees and asylum seekers and how they are affected globally; in addition, how their risk compares to that of the host-country population is unclear. We aimed to explore and assess global AMR data among refugees and asylum seekers. Ovid (MEDLINE and Embase) and PubMed were searched for peer-reviewed primary research articles from Jan 1, 2015, to Oct 23, 2023, and articles were included if they reported carriage or infection with laboratory-confirmed drug-resistant organisms in refugees or asylum seekers from any country. Of 884 articles identified, 41 reported prevalence of AMR among 16 970 refugees and asylum seekers and were included in the study. The most common phenotypes reported were multidrug-resistant Gram-negative bacteria (n=26; prevalence ranged from 4·2% to 60·8%), methicillin-resistant Staphylococcus aureus (n=24; 0·92% to 73%), and extended-spectrum β-lactamase-producing Gram-negative bacteria (n=20; 1·6% to 61·1%). Refugees and asylum seekers had a higher likelihood of carriage or infection with any AMR than the host-country population (n=7849 vs n=81 283, respectively; odds ratio 2·88, 95% CI 2·61-3·18; I2=94%). Refugees and asylum seekers are at an increased risk of AMR carriage and infection, with our data suggesting that refugees and asylum seekers might be exposed to conditions that support the emergence of drug resistance (including living in overcrowded camps and facing barriers to health and vaccine systems). Hence, more global and regional data on AMR are needed through strengthened surveillance programmes and health-care facilities, especially in low-income and middle-income countries. Increased efforts are needed to drive improvements in infection prevention and control (including vaccination), antimicrobial stewardship, treatment strategies tailored to groups at high risk, accessiblity to quality health care in these populations at risk globally, and address risk factors such as poor living and transit conditions.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Hermsen ED, Amos J, Townsend A, et al. Antimicrobial resistance among refugees and asylum seekers: a global systematic review and meta-analysis. Lancet Infect Dis. 2024. PMID: 39527961. doi:10.1016/S1473-3099(24)00578-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。